[Cationic trypsinogen gene mutation in patients with chronic idiopathic pancreatitis]. 2004

Woo Jin Lee, and Kyung-Ah Kim, and June Sung Lee, and Young Bin Jeon, and Ji Bong Jeong, and Ji Kon Ryu, and Yong-Tae Kim, and Yong Bum Yoon, and Chung Yong Kim
Center for Liver Cancer, National Cancer Center, Goyang, Korea.

OBJECTIVE Mutation of Cationic trypsinogen gene is clearly associated with hereditary pancreatitis and plays an important role in the pathogenesis of pancreatitis. According to literature, this mutation is occasionally occurred in patients with pancreatitis in Western countries and Japan. The aim of this study was to find out whether the mutation was observed in Korean patients with chronic idiopathic pancreatitis. METHODS Peripheral blood samples of 11 patients with chronic idiopathic pancreatitis were collected consecutively, and DNA was extracted from the samples. Polymerase chain reaction was performed in exon 2 and 3 of cationic trypsinogen gene. Then, DNA products were purified and sequenced. RESULTS The mutation was not found in exon 2 and 3 of cationic trypsinogen gene in these patients. CONCLUSIONS There was no cationic trypsinogen mutation in Korean patients with chronic idiopathic pancreatitis. Further large sampled cohort study is needed.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010195 Pancreatitis INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis. Acute Edematous Pancreatitis,Acute Pancreatitis,Pancreatic Parenchyma with Edema,Pancreatic Parenchymal Edema,Pancreatitis, Acute,Pancreatitis, Acute Edematous,Peripancreatic Fat Necrosis,Acute Edematous Pancreatitides,Acute Pancreatitides,Edema, Pancreatic Parenchymal,Edematous Pancreatitides, Acute,Edematous Pancreatitis, Acute,Fat Necrosis, Peripancreatic,Necrosis, Peripancreatic Fat,Pancreatic Parenchymal Edemas,Pancreatitides, Acute,Pancreatitides, Acute Edematous,Parenchymal Edema, Pancreatic,Peripancreatic Fat Necroses
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014357 Trypsin A serine endopeptidase that is formed from TRYPSINOGEN in the pancreas. It is converted into its active form by ENTEROPEPTIDASE in the small intestine. It catalyzes hydrolysis of the carboxyl group of either arginine or lysine. EC 3.4.21.4. Tripcellim,Trypure,beta-Trypsin,beta Trypsin

Related Publications

Woo Jin Lee, and Kyung-Ah Kim, and June Sung Lee, and Young Bin Jeon, and Ji Bong Jeong, and Ji Kon Ryu, and Yong-Tae Kim, and Yong Bum Yoon, and Chung Yong Kim
July 1999, Lancet (London, England),
Woo Jin Lee, and Kyung-Ah Kim, and June Sung Lee, and Young Bin Jeon, and Ji Bong Jeong, and Ji Kon Ryu, and Yong-Tae Kim, and Yong Bum Yoon, and Chung Yong Kim
March 2015, Human mutation,
Woo Jin Lee, and Kyung-Ah Kim, and June Sung Lee, and Young Bin Jeon, and Ji Bong Jeong, and Ji Kon Ryu, and Yong-Tae Kim, and Yong Bum Yoon, and Chung Yong Kim
November 2005, Gut,
Woo Jin Lee, and Kyung-Ah Kim, and June Sung Lee, and Young Bin Jeon, and Ji Bong Jeong, and Ji Kon Ryu, and Yong-Tae Kim, and Yong Bum Yoon, and Chung Yong Kim
September 2002, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
Woo Jin Lee, and Kyung-Ah Kim, and June Sung Lee, and Young Bin Jeon, and Ji Bong Jeong, and Ji Kon Ryu, and Yong-Tae Kim, and Yong Bum Yoon, and Chung Yong Kim
December 1999, Gastroenterology,
Woo Jin Lee, and Kyung-Ah Kim, and June Sung Lee, and Young Bin Jeon, and Ji Bong Jeong, and Ji Kon Ryu, and Yong-Tae Kim, and Yong Bum Yoon, and Chung Yong Kim
March 2001, Clinical genetics,
Woo Jin Lee, and Kyung-Ah Kim, and June Sung Lee, and Young Bin Jeon, and Ji Bong Jeong, and Ji Kon Ryu, and Yong-Tae Kim, and Yong Bum Yoon, and Chung Yong Kim
October 1998, Pancreas,
Woo Jin Lee, and Kyung-Ah Kim, and June Sung Lee, and Young Bin Jeon, and Ji Bong Jeong, and Ji Kon Ryu, and Yong-Tae Kim, and Yong Bum Yoon, and Chung Yong Kim
July 1999, Gastroenterology,
Woo Jin Lee, and Kyung-Ah Kim, and June Sung Lee, and Young Bin Jeon, and Ji Bong Jeong, and Ji Kon Ryu, and Yong-Tae Kim, and Yong Bum Yoon, and Chung Yong Kim
February 2000, The British journal of surgery,
Woo Jin Lee, and Kyung-Ah Kim, and June Sung Lee, and Young Bin Jeon, and Ji Bong Jeong, and Ji Kon Ryu, and Yong-Tae Kim, and Yong Bum Yoon, and Chung Yong Kim
October 1999, Lancet (London, England),
Copied contents to your clipboard!